Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13863105 | 0.88 | TSHR (0.47) | TSHRALDH1A1THRB | |
| SCHEMBL2189982 | 0.81 | TSHR (0.41) | TSHRALDH1A1THRB | |
| SCHEMBL94906 | 0.81 | TSHR (0.68) | TSHRALDH1A1THRB | |
| SCHEMBL29343526 | 0.79 | TSHR (0.49) | TSHRALDH1A1THRB | |
| SCHEMBL17805317 | 0.79 | TSHR (0.49) | TSHRALDH1A1THRB | |
| SCHEMBL29343527 | 0.79 | TSHR (0.49) | TSHRALDH1A1THRB | |
| SCHEMBL13863117 | 0.79 | TSHR (0.49) | TSHRALDH1A1THRB | |
| SCHEMBL3627742 | 0.79 | TSHR (0.49) | TSHRALDH1A1THRB | |
| SCHEMBL29343519 | 0.79 | TSHR (0.53) | TSHRALDH1A1THRB | |
| SCHEMBL19998240 | 0.79 | TSHR (0.65) | TSHRALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8349912-B2 | Crosslink agents and dual radical cure polymer | BAUSCH & LOMB INCORPORATED (US) | 2013-01-08 | — | — | US | claimed |
| US-20120004380-A1 | Crosslink Agents and Dual Radical Cure Polymer | BAUSCH HEALTH AMERICAS, INC. | 2012-01-05 | — | — | US | claimed |
| US-8053489-B2 | Crosslink agents and dual radical cure polymer | BAUSCH & LOMB INCORPORATED (US) | 2011-11-08 | — | — | US | claimed |
| EP-3424965-B1 | CROSSLINK AGENTS AND ITS USE | BAUSCH & LOMB (US) | 2020-05-13 | — | — | EP | disclosed |
| EP-3424965-A1 | CROSSLINK AGENTS AND DUAL RADICAL CURE POLYMER | Bausch & Lomb Incorporated (US) | 2019-01-09 | — | — | EP | disclosed |
| EP-2167555-B1 | CROSSLINK AGENTS AND DUAL RADICAL CURE POLYMER | BAUSCH & LOMB (US) | 2018-10-10 | — | — | EP | disclosed |
| US-8349912-B2 | Crosslink agents and dual radical cure polymer | BAUSCH & LOMB INCORPORATED (US) | 2013-01-08 | — | — | US | disclosed |
| US-8252850-B2 | Crosslink agents | BAUSCH & LOMB INCORPORATED (US) | 2012-08-28 | — | — | US | disclosed |
| US-8119753-B2 | Silicone hydrogels with amino surface groups | BAUSCH & LOMB INCORPORATED (US) | 2012-02-21 | — | — | US | disclosed |
| US-20120004380-A1 | Crosslink Agents and Dual Radical Cure Polymer | BAUSCH HEALTH AMERICAS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-8053489-B2 | Crosslink agents and dual radical cure polymer | BAUSCH & LOMB INCORPORATED (US) | 2011-11-08 | — | — | US | disclosed |
| EP-2170966-A1 | CROSSLINK AGENTS AND DUAL RADICAL CURE POLYMER | Bausch & Lomb Incorporated (US) | 2010-04-07 | — | — | EP | disclosed |
| EP-2167555-A1 | CROSSLINK AGENTS AND DUAL RADICAL CURE POLYMER | Bausch & Lomb Incorporated (US) | 2010-03-31 | — | — | EP | disclosed |
| WO-2009111296-A1 | POLYSILOXANES AND POLYSILOXANE PREPOLYMERS WITH VINYL OR EPOXY FUNCTIONALITY | BAUSCH & LOMB INCORPORATED (US) | 2009-09-11 | — | — | WO | disclosed |
| US-20090227804-A1 | POLYSILOXANES AND POLYSILOXANE PREPOLYMERS WITH VINYL OR EPOXY FUNCTIONALITY | PRECISION DERMATOLOGY, INC. | 2009-09-10 | — | — | US | disclosed |
| US-20090103045-A1 | SILICONE HYDROGELS WITH AMINO SURFACE GROUPS | SALIX PHARMACEUTICALS, INC. | 2009-04-23 | — | — | US | disclosed |
| WO-2009014923-A1 | CROSSLINK AGENTS AND DUAL RADICAL CURE POLYMER | BAUSCH & LOMB INCORPORATED (US) | 2009-01-29 | — | — | WO | disclosed |
| US-20090023876-A1 | Crosslink Agents and Dual Radical Cure Polymer | MEDICIS PHARMACEUTICAL CORPORATION | 2009-01-22 | — | — | US | disclosed |
| US-20090018233-A1 | Crosslink Agents and Dual Radical Cure Polymer | SOLTA MEDICAL, INC. | 2009-01-15 | — | — | US | disclosed |
| WO-2009009527-A1 | CROSSLINK AGENTS AND DUAL RADICAL CURE POLYMER | BAUSCH & LOMB INCORPORATED (US) | 2009-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018233-A1 | Crosslink Agents and Dual Radical Cure Polymer | UACA, CRYAA, RAD51 | TSHR 2555/4885ALDH1A1 1327/4885THRB 4577/4885 |
| US-20090227804-A1 | POLYSILOXANES AND POLYSILOXANE PREPOLYMERS WITH VINYL OR EPOXY FUNCTIONALITY | MUS81, UTS2R, C1R | TSHR 2214/4885ALDH1A1 2339/4885THRB 3182/4885 |
| US-20120004380-A1 | Crosslink Agents and Dual Radical Cure Polymer | UACA, CRYAA, PCNA | TSHR 2788/4885ALDH1A1 883/4885THRB 4718/4885 |
| US-20090023876-A1 | Crosslink Agents and Dual Radical Cure Polymer | UACA, CRYAA, PCNA | TSHR 2788/4885ALDH1A1 883/4885THRB 4718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.